Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V} -- Ignore unavailable to you. Want to Upgrade?

To: BRAVEHEART who wrote (297)	3/14/2000 12:58:00 PM
From: tuck	Read Replies (2) \| Respond to of 423

Jeffrey, Bought some DRAX @ 3/18. My research is superficial to date, so I'm relying on you a bit here in shooting from the hip. This drop does look like a market maker head fake to shake the tree and get clients in for a run to Gruntal's short-term (they do not define this) target of $7. Wonder if it's them walking it down? I'm starting to look into LevelII, and premium insider/SEC feeds. Tired of wondering. USON. Do you see immediate evidence of improving margins or revenue growth? Analysts don't. Managed care under a cloud, as you've pointed out; might be a bit early for this one. Turnaround story interesting. Insider buying and T/A pretty compelling, too. I'll have to dig some more. CYGN back over 16. Cheers, Tuck